We are live on ! Find out more
TNDM icon

Tandem Diabetes Care
TNDM

66 hedge funds and large institutions have $160M invested in Tandem Diabetes Care in 2014 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 21

2% less call options, than puts

Call options by funds: $1.27M | Put options by funds: $1.29M

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

4% less funds holding

Funds holding: 69 → 66 (-3)

5% less capital invested

Capital invested by funds: $170M → $160M (-$9.2M)

Holders
66
Holders Change
-3
Holders Change %
-4.35%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
21
Reduced
21
Closed
14
Calls
$1.27M
Puts
$1.29M
Net Calls
-$20K
Net Calls Change
+$493K

Top Buyers

Rank Fund Capital Flow
1
BA
BlackRock Advisors
Delaware
+$5.74M
2
Franklin Resources
Franklin Resources
California
+$5.05M
3
ACM
Apex Capital Management
Ohio
+$4.42M
4
RPAM
Rhenman & Partners Asset Management
Sweden
+$2.48M
5
Goldman Sachs
Goldman Sachs
New York
+$1.43M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$7.93M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$7.4M
3
CAM
Cortina Asset Management
Wisconsin
-$4.7M
4
VAM
Visium Asset Management
New York
-$1.05M
5
CCM
Cadence Capital Management
Massachusetts
-$908K
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
51
Teachers Advisors
New York
$151K – – –
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$87K +$91.5K +660 +2,200%
NFA
53
Nationwide Fund Advisors
Ohio
$81K – – –
Morgan Stanley
54
Morgan Stanley
New York
$81K +$9.98K +72 +13%
AIG
55
American International Group
New York
$66.9K -$2.91K -21 -4%
Citigroup
56
Citigroup
New York
$30K -$3.05K -22 -9%
TRCT
57
Tower Research Capital (TRC)
New York
$26K +$29K +209 New
US Bancorp
58
US Bancorp
Minnesota
$17K -$7.9K -57 -30%
MWP
59
MYCIO Wealth Partners
Pennsylvania
$13K – – –
PNC Financial Services Group
60
PNC Financial Services Group
Pennsylvania
$10K +$11.6K +84 New
Barclays
61
Barclays
United Kingdom
$8K -$7.9K -57 -46%
LTFS
62
Ladenburg Thalmann Financial Services
Florida
$6K +$6.66K +48 New
FHA
63
First Horizon Advisors
Tennessee
$3K +$3.6K +26 New
UBS Group
64
UBS Group
Switzerland
$2K +$2.22K +16 New
MFS
65
MSI Financial Services
Massachusetts
$1K – – –
Bank of Montreal
66
Bank of Montreal
Ontario, Canada
$1K +$693 +5 New
VAM
67
Visium Asset Management
New York
– -$1.05M -7,860 Closed
CCM
68
Cadence Capital Management
Massachusetts
– -$908K -6,765 Closed
RFC
69
Regions Financial Corp
Alabama
– -$273K -2,037 Closed
PP
70
PDT Partners
New York
– -$231K -1,722 Closed
OC
71
Oppenheimer & Co
New York
– -$219K -1,630 Closed
SB
72
Suntrust Banks
Georgia
– -$212K -1,582 Closed
DY
73
Dowling & Yahnke
California
– -$136K -1,014 Closed
MCM
74
Manchester Capital Management
Vermont
– -$125K -1,000 Closed
Group One Trading
75
Group One Trading
Illinois
– -$112K -810 Closed
1 2
3
4

TNDM Hedge Fund Activity: Q4 2014 in Review

66 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q4 2014, worth a combined $160M — down 5.4% from $170M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of TNDM and 13 opened new positions — a net loss of 1 holder — while 21 trimmed existing stakes and 21 added.

The largest buyer was BlackRock Advisors, adding an estimated $5.74M. The largest seller was Jennison Associates, cutting an estimated $7.93M.

  • 66 institutional investors held Tandem Diabetes Care (TNDM) as of Q4 2014, down from 69 in Q3 2014.
  • Funds reported $160M of Tandem Diabetes Care stock for Q4 2014, down 5.4% quarter-over-quarter.
  • 13 funds opened new Tandem Diabetes Care positions in Q4 2014 and 14 closed out, a net change of -1 holder.
  • The largest Tandem Diabetes Care buyer in Q4 2014 was BlackRock Advisors, an estimated $5.74M added.
  • The largest Tandem Diabetes Care seller in Q4 2014 was Jennison Associates, an estimated $7.93M sold.

Based on aggregated 13F filings for Q4 2014.